Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty

Masaya Shinohara,R Wada,Shintaro Yao,Kensuke Yano,Katsuya Akitsu,Hideki Koike,Toshio Kinoshita,Hitomi Yuzawa,Takeya Suzuki,Tadashi Fujino,Takanori Ikeda

Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty

2019

Masaya Shinohara
R Wada
Shintaro Yao
Kensuke Yano
Katsuya Akitsu
Hideki Koike
Toshio Kinoshita
Hitomi Yuzawa
Takeya Suzuki
Tadashi Fujino
Takanori Ikeda

Background The safety and efficacy of an oral anticoagulant (OAC) treatment and the difference between direct OACs (DOACs) and warfarin in nonsevere frail elderly patients with AF are unclear.

Keywords:

Internal medicine
Warfarin
Atrial fibrillation
Anesthesia
Cardiology
Medicine
Hazard ratio
significant difference
Incidence (epidemiology)
frail elderly
Confidence interval
Observational study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations